Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with <i>KCNT1</i> Genetic Variants
Quinidine (QND) is an old antimalarial drug that was used in the early 20th century as an antiarrhythmic agent. Currently, QND is receiving attention for its use in epilepsy of infancy with migrating focal seizures (EIMFS) due to potassium sodium-activated channel subfamily T member 1 (<i>KCNT...
Saved in:
Main Authors: | Alessandro Ferretti (Author), Raffaele Simeoli (Author), Sara Cairoli (Author), Nicola Pietrafusa (Author), Marina Trivisano (Author), Carlo Dionisi Vici (Author), Nicola Specchio (Author), Bianca Maria Goffredo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy
by: M. C. Kravetz, et al.
Published: (2021) -
Concurrent Quinidine and Phenobarbital in the Treatment of a Patient with 2 KCNT1 Mutations
by: Camerin C. Passey, PharmD, MBA, et al.
Published: (2019) -
Use of Antibiotics in Preterm Newborns
by: Raffaele Simeoli, et al.
Published: (2022) -
A New and Rapid LC-MS/MS Method for the Determination of Cysteamine Plasma Levels in Cystinosis Patients
by: Raffaele Simeoli, et al.
Published: (2024) -
Changing Times for CLN2 Disease: The Era of Enzyme Replacement Therapy
by: Specchio N, et al.
Published: (2020)